Free Trial

Willow Biosciences (WLLW) Insider Trading & Ownership

Willow Biosciences logo
C$0.06 -0.02 (-20.00%)
(As of 05:28 PM ET)

Willow Biosciences (TSE:WLLW) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
24.34%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
C$4,207.50
Number Of
Insiders Selling
(Last 12 Months)
0
Get WLLW Insider Trade Alerts

Want to know when executives and insiders are buying or selling Willow Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

WLLW Insider Buying and Selling by Quarter

Willow Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/14/2024Travis DoupeSenior OfficerBuy49,500C$0.09C$4,207.50
(Data available from 1/1/2013 forward)

WLLW Insider Trading Activity - Frequently Asked Questions

The list of insiders at Willow Biosciences includes Christopher Kenneth Savile, Peter Seufer-Wasserthal, and Travis Doupe. Learn more on insiders at WLLW.

24.34% of Willow Biosciences stock is owned by insiders. Learn more on WLLW's insider holdings.

The following insiders have purchased WLLW shares in the last 24 months: Christopher Kenneth Savile (C$3,750.00), and Travis Doupe (C$4,207.50).

Insiders have purchased a total of 99,500 WLLW shares in the last 24 months for a total of C$7,957.50 bought.

Willow Biosciences Key Executives

  • Dr. Chris Savile
    President, Director & CEO
  • Mr. Travis Doupe (Age 52)
    Chief Financial Officer
    Compensation: $378.12k
    1 recent trades
  • Dr. Trish Choudhary
    Senior Vice President of Research & Development
  • Mr. Troy T. Talkkari
    Vice President of Corporate Development
  • Mr. Sanjib Singh Gill L.L.B. (Age 48)
    Corporate Secretary


This page (TSE:WLLW) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners